![](/img/cover-not-exists.png)
Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
Kaku, K., Araki, T., Yoshinaka, R.Volume:
36
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc12-0872
Date:
February, 2013
File:
PDF, 295 KB
english, 2013